Filed Pursuant to Rule 433
Registration Statement No. 333-223095
Issuer Free Writing Prospectus, dated February 22, 2018
Boston Scientific Corporation
$1,000,000,000
Senior Notes Offering
Terms and Conditions — 10-Year Fixed Rate Notes
Issuer |
| Boston Scientific Corporation |
|
|
|
Note Type |
| Senior Notes |
|
|
|
Form of Offering |
| SEC Registered |
|
|
|
Ratings(1) |
| Baa2/BBB-/BBB (stable/stable/stable) |
|
|
|
Principal Amount |
| $1,000,000,000 |
|
|
|
Trade Date |
| February 22, 2018 |
|
|
|
Settlement Date (T+2) |
| February 26, 2018 |
|
|
|
Maturity Date |
| March 1, 2028 |
|
|
|
Coupon |
| 4.000% per annum |
|
|
|
Yield to Maturity |
| 4.021% per annum |
|
|
|
Price to Public |
| 99.828% |
|
|
|
Spread to Benchmark Treasury |
| Plus 110 basis points |
|
|
|
Benchmark Treasury |
| 2.750% UST due February 15, 2028 |
|
|
|
Benchmark Treasury Yield |
| 2.921% |
|
|
|
Benchmark Treasury Price |
| 98-17 |
|
|
|
Interest Payment Dates |
| Semi-annually on March 1 and September 1 |
|
|
|
First Interest Payment Date |
| September 1, 2018 |
|
|
|
Make-whole Call |
| Plus 20 basis points |
|
|
|
Day Count Basis |
| 30/360 |
|
|
|
Minimum Denominations |
| $2,000 and integral multiples of $1,000 in excess of such amount |
|
|
|
CUSIP / ISIN |
| 101137AS6 / US101137AS67 |
|
|
|
Joint Bookrunners |
| Barclays Capital Inc. Citigroup Global Markets Inc. Merrill Lynch, Pierce, Fenner & Smith Incorporated Deutsche Bank Securities Inc. J.P. Morgan Securities LLC Wells Fargo Securities, LLC |
|
|
|
Co-Managers |
| BNP Paribas Securities Corp. |
|
| DNB Markets, Inc. MUFG Securities Americas Inc. RBC Capital Markets, LLC Scotia Capital (USA) Inc. SMBC Nikko Securities America, Inc. Standard Chartered Bank TD Securities (USA) LLC U.S. Bancorp Investments, Inc. |
Note:
(1) A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.
The Issuer has filed a registration statement (including a preliminary prospectus supplement and accompanying prospectus) with the U.S. Securities and Exchange Commission (the “SEC”) for the offering to which this communication relates. Before you invest, you should read the preliminary prospectus supplement and accompanying prospectus and other documents the Issuer has filed with the SEC for more complete information about the Issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the Issuer, any underwriter or any dealer participating in the offering will arrange to send you the preliminary prospectus supplement and accompanying prospectus if you request it by calling Barclays Capital Inc. toll-free at (888) 603-5847, Citigroup Global Markets Inc. toll-free at (800) 831-9146 or Merrill Lynch, Pierce, Fenner & Smith Incorporated toll-free at (800) 294-1322.
Any disclaimers or other notices that may appear below are not applicable to this communication and should be disregarded. Such disclaimers or other notices were automatically generated as a result of this communication being sent via Bloomberg or another email system.
